Total voting rights

RNS Number : 4189P
The MedicX Fund Limited
01 October 2013
 



 

 

Press Release

For immediate release

1 October 2013

 

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Total voting rights

 

In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 30 September 2013 was 274,906,714 (excluding treasury shares) with each share holding one voting right.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

 

The Company also holds 1,539,066 ordinary shares in treasury.

 

The total voting rights and number of shares held in treasury stated above supersede the numbers noted in the scrip dividend declaration announcement issued on 23 September 2013.

 

 

 

End

 

 

For further information please contact:

 

MedicX Group                                                               +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

 

Canaccord Genuity Limited                                             +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith

 

Buchanan Communications                                             +44 (0) 20 7466 5000

Charles Ryland/Sophie McNulty/Helen Greenwood

 

MedicX Fund Limited                                                      +44 (0) 1481 723 450

David Staples, Chairman

 

 

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 123 properties.

 

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.

 

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGGAPUUPWGPG
UK 100

Latest directors dealings